PALIPERIDONE PALMITATE

PALIPERIDONE PALMITATE was reported 32681 times

These side effects are most commonly reported by patients taking PALIPERIDONE PALMITATE:

# Side effect Count
0 OFF LABEL USE 3485
1 DRUG INEFFECTIVE 2233
2 HOSPITALISATION 1836
3 WEIGHT INCREASED 1699
4 PRODUCT DOSE OMISSION ISSUE 1460
5 DRUG DOSE OMISSION 1417
6 SCHIZOPHRENIA 1151
7 GYNAECOMASTIA 1085
8 CONDITION AGGRAVATED 996
9 TREATMENT NONCOMPLIANCE 962
10 BLOOD PROLACTIN INCREASED 954
11 PSYCHOTIC DISORDER 916
12 INCORRECT DOSE ADMINISTERED 886
13 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 785
14 THERAPEUTIC RESPONSE DECREASED 767
15 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 741
16 INJECTION SITE PAIN 709
17 GALACTORRHOEA 706
18 HALLUCINATION, AUDITORY 685
19 PRODUCT USE IN UNAPPROVED INDICATION 653
20 INSOMNIA 647
21 DEATH 632
22 DEPRESSION 619
23 ANXIETY 598
24 FATIGUE 561
25 TREMOR 537
26 ADVERSE EVENT 533
27 AKATHISIA 527
28 INJECTION SITE NODULE 521
29 SOMNOLENCE 504
30 SEDATION 502
31 FEELING ABNORMAL 493
32 MALAISE 492
33 AGGRESSION 485
34 SUICIDAL IDEATION 481
35 DYSKINESIA 473
36 EXTRAPYRAMIDAL DISORDER 471
37 PRODUCT USE ISSUE 456
38 DIZZINESS 441
39 UNDERDOSE 434
40 ABNORMAL BEHAVIOUR 429
41 HALLUCINATION 425
42 DYSTONIA 415
43 ADVERSE DRUG REACTION 413
44 AMENORRHOEA 412
45 PARANOIA 408
46 SEXUAL DYSFUNCTION 388
47 DELUSION 387
48 PRODUCT DOSE OMISSION 381
49 AGITATION 379
50 INJECTION SITE MASS 378
51 SUICIDE ATTEMPT 378
52 SYRINGE ISSUE 371
53 DRUG EFFECT DECREASED 368
54 HYPERPROLACTINAEMIA 367
55 REFUSAL OF TREATMENT BY PATIENT 355
56 HEADACHE 350
57 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 347
58 TARDIVE DYSKINESIA 336
59 ABNORMAL WEIGHT GAIN 331
60 RESTLESSNESS 315
61 BLOOD GLUCOSE INCREASED 306
62 ERECTILE DYSFUNCTION 299
63 BLOOD PROLACTIN ABNORMAL 292
64 DYSPNOEA 280
65 PAIN 276
66 THERAPEUTIC PRODUCT EFFECT DECREASED 273
67 MUSCULOSKELETAL STIFFNESS 269
68 NEEDLE ISSUE 263
69 INJECTION SITE REACTION 259
70 DISTURBANCE IN SOCIAL BEHAVIOUR 258
71 WEIGHT DECREASED 255
72 PRODUCT QUALITY ISSUE 254
73 EMOTIONAL DISORDER 251
74 GAIT DISTURBANCE 243
75 ASTHENIA 242
76 NEUROLEPTIC MALIGNANT SYNDROME 234
77 METABOLIC DISORDER 233
78 OVERDOSE 230
79 ACCIDENTAL EXPOSURE TO PRODUCT 224
80 NAUSEA 224
81 DROOLING 223
82 MANIA 223
83 CONFUSIONAL STATE 218
84 DRUG ABUSE 218
85 PSYCHOTIC SYMPTOM 217
86 VOMITING 217
87 ANOSOGNOSIA 214
88 PERSONALITY CHANGE 213
89 SEIZURE 206
90 VISION BLURRED 203
91 CONSTIPATION 202
92 COMPLETED SUICIDE 199
93 PAIN IN EXTREMITY 199
94 IRRITABILITY 198
95 RASH 192
96 FALL 191
97 MENTAL DISORDER 191
98 DEVICE LEAKAGE 188
99 PNEUMONIA 187
100 INJECTION SITE SWELLING 186
101 OBESITY 184
102 DRUG INTERACTION 183
103 MEMORY IMPAIRMENT 179
104 SCHIZOAFFECTIVE DISORDER 175
105 HYPERTENSION 167
106 TACHYCARDIA 167
107 HYPERSOMNIA 164
108 THINKING ABNORMAL 164
109 LOSS OF CONSCIOUSNESS 162
110 EMOTIONAL DISTRESS 161
111 SPEECH DISORDER 158
112 CHEST PAIN 156
113 MENTAL IMPAIRMENT 152
114 PARKINSONISM 151
115 APATHY 150
116 DIARRHOEA 150
117 DISTURBANCE IN ATTENTION 149
118 HYPOAESTHESIA 149
119 LETHARGY 148
120 COGNITIVE DISORDER 145
121 MEDICATION ERROR 144
122 PYREXIA 144
123 DECREASED APPETITE 143
124 HYPOTENSION 142
125 MYALGIA 141
126 MUSCLE SPASMS 138
127 MUSCLE RIGIDITY 136
128 ANGER 131
129 HYPERHIDROSIS 130
130 DEVICE MALFUNCTION 129
131 MUSCLE TWITCHING 124
132 DIABETES MELLITUS 122
133 HEART RATE INCREASED 122
134 HYPERSENSITIVITY 121
135 DYSPHAGIA 117
136 DELIRIUM 116
137 MUSCULAR WEAKNESS 116
138 PULMONARY EMBOLISM 116
139 RHABDOMYOLYSIS 116
140 DRUG ADMINISTRATION ERROR 114
141 INJECTION SITE ERYTHEMA 114
142 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 114
143 ARTHRALGIA 112
144 PALPITATIONS 112
145 PRODUCT ADMINISTRATION ERROR 112
146 PRODUCT STORAGE ERROR 111
147 BREAST DISCHARGE 108
148 SYNCOPE 108
149 VISUAL IMPAIRMENT 107
150 AMNESIA 104
151 DYSARTHRIA 104
152 INCREASED APPETITE 103
153 RENAL IMPAIRMENT 103
154 BREAST ENLARGEMENT 102
155 DEVICE ISSUE 102
156 NEUTROPENIA 100
157 DEPRESSED MOOD 99
158 PRURITUS 99
159 EXPOSURE DURING PREGNANCY 98
160 ALOPECIA 97
161 CATATONIA 97
162 EYE MOVEMENT DISORDER 95
163 PERIPHERAL SWELLING 94
164 ANHEDONIA 93
165 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 93
166 SALIVARY HYPERSECRETION 93
167 PRODUCT LEAKAGE 91
168 BIPOLAR DISORDER 90
169 LOSS OF LIBIDO 90
170 BACK PAIN 89
171 DRY MOUTH 87
172 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 85
173 LIBIDO DECREASED 84
174 MYOCARDIAL INFARCTION 83
175 SOCIAL AVOIDANT BEHAVIOUR 83
176 WHITE BLOOD CELL COUNT DECREASED 83
177 MOVEMENT DISORDER 82
178 NERVOUSNESS 82
179 URINARY INCONTINENCE 82
180 GENERAL PHYSICAL HEALTH DETERIORATION 80
181 INCORRECT ROUTE OF DRUG ADMINISTRATION 80
182 EATING DISORDER 79
183 BLOOD CREATINE PHOSPHOKINASE INCREASED 78
184 SLEEP DISORDER 77
185 BLOOD PRESSURE INCREASED 76
186 CARDIAC DISORDER 76
187 CEREBROVASCULAR ACCIDENT 76
188 INTENTIONAL SELF-INJURY 76
189 SUBSTANCE ABUSE 76
190 ILLNESS 75
191 IMPRISONMENT 75
192 BLOOD CHOLESTEROL INCREASED 74
193 PRODUCT PRESCRIBING ERROR 74
194 FEAR 73
195 HYPOKINESIA 73
196 PARAESTHESIA 73
197 DEHYDRATION 72
198 FLAT AFFECT 72
199 HALLUCINATION, VISUAL 71
200 NIGHTMARE 71
201 DRUG ADMINISTERED AT INAPPROPRIATE SITE 70
202 INJECTION SITE RASH 70
203 SWOLLEN TONGUE 69
204 BALANCE DISORDER 68
205 EXTRA DOSE ADMINISTERED 68
206 DISABILITY 67
207 URTICARIA 67
208 HOMICIDAL IDEATION 66
209 PRODUCT PACKAGING ISSUE 66
210 EXPIRED PRODUCT ADMINISTERED 65
211 INJECTION SITE INDURATION 64
212 DEVICE OCCLUSION 63
213 DISORIENTATION 63
214 HYPONATRAEMIA 62
215 SWELLING FACE 62
216 DRUG PRESCRIBING ERROR 61
217 INSURANCE ISSUE 61
218 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 61
219 THERAPEUTIC RESPONSE SHORTENED 60
220 THERAPY CESSATION 60
221 ELECTROCARDIOGRAM QT PROLONGED 59
222 HEPATIC ENZYME INCREASED 59
223 WRONG TECHNIQUE IN DRUG USAGE PROCESS 59
224 ABDOMINAL PAIN UPPER 58
225 PANIC ATTACK 58
226 CRYING 57
227 DISCOMFORT 57
228 STRESS 57
229 APHASIA 56
230 BREAST TENDERNESS 56
231 COUGH 56
232 POLLAKIURIA 56
233 SWELLING 56
234 DEEP VEIN THROMBOSIS 55
235 DRUG INTOLERANCE 55
236 EMOTIONAL POVERTY 55
237 INJURY 55
238 OEDEMA PERIPHERAL 55
239 ORTHOSTATIC HYPOTENSION 54
240 PSYCHOMOTOR HYPERACTIVITY 54
241 URINARY TRACT INFECTION 54
242 DRUG HYPERSENSITIVITY 53
243 MOOD SWINGS 53
244 TOXICITY TO VARIOUS AGENTS 53
245 CARDIAC ARREST 52
246 RESTLESS LEGS SYNDROME 52
247 DYSPHONIA 51
248 GAIT INABILITY 51
249 PERSECUTORY DELUSION 51
250 PSYCHIATRIC SYMPTOM 51
251 SINUS TACHYCARDIA 51
252 THROMBOSIS 51
253 COVID-19 50
254 INTESTINAL OBSTRUCTION 50
255 SELF-MEDICATION 50
256 ACUTE KIDNEY INJURY 49
257 HYPERGLYCAEMIA 49
258 IMPAIRED WORK ABILITY 49
259 INJECTION SITE ABSCESS 49
260 OCULOGYRIC CRISIS 49
261 RENAL FAILURE 49
262 BLOOD TRIGLYCERIDES INCREASED 48
263 LEUKOPENIA 48
264 OVERWEIGHT 48
265 WRONG PRODUCT ADMINISTERED 48
266 ABDOMINAL PAIN 47
267 ERYTHEMA 47
268 HALLUCINATIONS, MIXED 47
269 PRIAPISM 47
270 WITHDRAWAL SYNDROME 47
271 PARKINSON^S DISEASE 46
272 INCOHERENT 45
273 INJECTION SITE EXTRAVASATION 45
274 UNEVALUABLE EVENT 45
275 ARRHYTHMIA 44
276 CHEST DISCOMFORT 44
277 DRY EYE 44
278 FEELING HOT 44
279 INVESTIGATION 44
280 POOR QUALITY SLEEP 44
281 SLUGGISHNESS 44
282 SOLILOQUY 44
283 DEMENTIA 43
284 DRUG LEVEL INCREASED 43
285 INCORRECT PRODUCT STORAGE 43
286 MIGRAINE 43
287 BLUNTED AFFECT 42
288 DEPRESSED LEVEL OF CONSCIOUSNESS 42
289 EJACULATION FAILURE 42
290 MOBILITY DECREASED 42
291 PSYCHOSEXUAL DISORDER 42
292 BRUXISM 41
293 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 41
294 DRUG SCREEN POSITIVE 41
295 GASTROINTESTINAL DISORDER 41
296 MENSTRUATION IRREGULAR 41
297 TRISMUS 41
298 WRONG DRUG ADMINISTERED 41
299 BONE PAIN 40
300 CELLULITIS 40
301 INTENTIONAL OVERDOSE 40
302 MENTAL STATUS CHANGES 40
303 URINARY RETENTION 40
304 WHITE BLOOD CELL COUNT INCREASED 40
305 ABDOMINAL DISTENSION 39
306 BLOOD PRESSURE DECREASED 39
307 BLOOD TESTOSTERONE DECREASED 39
308 INCONTINENCE 39
309 INTENTIONAL PRODUCT MISUSE 39
310 TINNITUS 39
311 BRADYCARDIA 38
312 EPILEPSY 38
313 INFLUENZA LIKE ILLNESS 38
314 MYOCARDITIS 38
315 NODULE 38
316 NONSPECIFIC REACTION 38
317 SUDDEN DEATH 38
318 BLINDNESS 37
319 BREAST CANCER 37
320 COMA 37
321 CONTUSION 37
322 DRUG EFFECT INCOMPLETE 37
323 PSYCHIATRIC DECOMPENSATION 37
324 SEDATION COMPLICATION 37
325 THIRST 37
326 ABDOMINAL DISCOMFORT 36
327 ALTERED STATE OF CONSCIOUSNESS 36
328 BRAIN INJURY 36
329 INFECTION 36
330 RETROGRADE EJACULATION 36
331 THROMBOCYTOPENIA 36
332 ANAEMIA 35
333 BEDRIDDEN 35
334 DECREASED INTEREST 35
335 INFLUENZA 35
336 MOOD ALTERED 35
337 SENSORY DISTURBANCE 35
338 CHILLS 34
339 HEAD DISCOMFORT 34
340 INJECTION SITE HAEMORRHAGE 34
341 INJURY ASSOCIATED WITH DEVICE 34
342 MOTOR DYSFUNCTION 34
343 MUSCLE TIGHTNESS 34
344 AFFECT LABILITY 33
345 ANORGASMIA 33
346 BEHAVIOUR DISORDER 33
347 PARALYSIS 33
348 PSORIASIS 33
349 THERAPEUTIC RESPONSE UNEXPECTED 33
350 TYPE 2 DIABETES MELLITUS 33
351 UNRESPONSIVE TO STIMULI 33
352 BURNING SENSATION 32
353 ENCEPHALOPATHY 32
354 EPISTAXIS 32
355 EYE IRRITATION 32
356 HUNGER 32
357 INJECTION SITE INFECTION 32
358 INJECTION SITE PRURITUS 32
359 INTENTIONAL PRODUCT USE ISSUE 32
360 LOGORRHOEA 32
361 OBSESSIVE-COMPULSIVE DISORDER 32
362 PITUITARY TUMOUR 32
363 SCREAMING 32
364 TREATMENT FAILURE 32
365 ACNE 31
366 BRADYKINESIA 31
367 PLATELET COUNT DECREASED 31
368 BLOOD SODIUM DECREASED 30
369 CONJUNCTIVITIS 30
370 EJACULATION DISORDER 30
371 NASOPHARYNGITIS 30
372 NEUTROPHIL COUNT DECREASED 30
373 PHYSICAL ASSAULT 30
374 TOBACCO USER 30
375 BRAIN FOG 29
376 C-REACTIVE PROTEIN INCREASED 29
377 DRUG DEPENDENCE 29
378 HYPERPHAGIA 29
379 INJECTION SITE BRUISING 29
380 NECK PAIN 29
381 PANCREATITIS 29
382 PROCEDURAL COMPLICATION 29
383 PRODUCT LABEL ISSUE 29
384 TACHYPHRENIA 29
385 ACUTE PSYCHOSIS 28
386 ASPIRATION 28
387 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 28
388 INJECTION SITE WARMTH 28
389 LIQUID PRODUCT PHYSICAL ISSUE 28
390 NEOPLASM MALIGNANT 28
391 ALANINE AMINOTRANSFERASE INCREASED 27
392 BODY TEMPERATURE INCREASED 27
393 DRUG LEVEL DECREASED 27
394 GLYCOSYLATED HAEMOGLOBIN INCREASED 27
395 HEART RATE IRREGULAR 27
396 HYPOTHYROIDISM 27
397 LANGUAGE DISORDER 27
398 MAJOR DEPRESSION 27
399 MUSCLE ATROPHY 27
400 NERVOUS SYSTEM DISORDER 27
401 POOR PERSONAL HYGIENE 27
402 RENAL DISORDER 27
403 ROAD TRAFFIC ACCIDENT 27
404 STARING 27
405 SUBSTANCE USE 27
406 ACTIVITIES OF DAILY LIVING IMPAIRED 26
407 BREAST PAIN 26
408 CARDIOVASCULAR DISORDER 26
409 CHOKING 26
410 HOSTILITY 26
411 HYPOTHERMIA 26
412 IMPAIRED SELF-CARE 26
413 LIVER DISORDER 26
414 MUSCULOSKELETAL PAIN 26
415 OXYGEN SATURATION DECREASED 26
416 PRODUCT DISPENSING ERROR 26
417 RHINORRHOEA 26
418 AFFECTIVE DISORDER 25
419 ANGINA PECTORIS 25
420 CARDIAC FAILURE 25
421 CEREBRAL DISORDER 25
422 FOETAL EXPOSURE DURING PREGNANCY 25
423 GLUCOSE TOLERANCE IMPAIRED 25
424 NERVE INJURY 25
425 OROPHARYNGEAL PAIN 25
426 SLEEP APNOEA SYNDROME 25
427 SURGERY 25
428 ABNORMAL DREAMS 24
429 ACCIDENTAL OVERDOSE 24
430 ANAL INCONTINENCE 24
431 ANGIOEDEMA 24
432 ANTIPSYCHOTIC DRUG LEVEL INCREASED 24
433 ASPARTATE AMINOTRANSFERASE INCREASED 24
434 BRADYPHRENIA 24
435 CONVULSION 24
436 DRY SKIN 24
437 ENURESIS 24
438 EUPHORIC MOOD 24
439 EYE DISORDER 24
440 INJECTION SITE CELLULITIS 24
441 INJECTION SITE DISCOMFORT 24
442 LACTATION DISORDER 24
443 POISONING 24
444 PRODUCT AVAILABILITY ISSUE 24
445 STEREOTYPY 24
446 ANAPHYLACTIC REACTION 23
447 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23
448 COMMUNICATION DISORDER 23
449 DIABETIC KETOACIDOSIS 23
450 EYE PAIN 23
451 HAEMORRHAGE 23
452 IMPAIRED QUALITY OF LIFE 23
453 IMPULSIVE BEHAVIOUR 23
454 INFERTILITY 23
455 JOINT STIFFNESS 23
456 LIMB DISCOMFORT 23
457 PANCREATITIS ACUTE 23
458 PITUITARY TUMOUR BENIGN 23
459 POLYDIPSIA 23
460 POST-TRAUMATIC STRESS DISORDER 23
461 PRODUCT COMPLAINT 23
462 SKIN DISCOLOURATION 23
463 THERAPY NON-RESPONDER 23
464 ABNORMAL LOSS OF WEIGHT 22
465 ALCOHOL USE 22
466 BOREDOM 22
467 COMPLICATION ASSOCIATED WITH DEVICE 22
468 COORDINATION ABNORMAL 22
469 DRUG RESISTANCE 22
470 DYSSTASIA 22
471 DYSURIA 22
472 HAEMOGLOBIN DECREASED 22
473 HEAD INJURY 22
474 HYPOAESTHESIA ORAL 22
475 LIP SWELLING 22
476 LIVING IN RESIDENTIAL INSTITUTION 22
477 OEDEMA 22
478 PRODUCT CONTAINER SEAL ISSUE 22
479 RASH GENERALISED 22
480 SOCIAL PROBLEM 22
481 ACCIDENTAL EXPOSURE 21
482 DIPLOPIA 21
483 DYSPEPSIA 21
484 ECZEMA 21
485 FEAR OF INJECTION 21
486 HYPOPHAGIA 21
487 INFLAMMATION 21
488 NASAL CONGESTION 21
489 RESPIRATORY DISORDER 21
490 AGRANULOCYTOSIS 20
491 BLISTER 20
492 BLOOD PRESSURE ABNORMAL 20
493 CATARACT 20
494 JOINT SWELLING 20
495 MENSTRUAL DISORDER 20
496 MUSCLE DISORDER 20
497 PALLOR 20
498 PHOTOPHOBIA 20
499 QUALITY OF LIFE DECREASED 20
500 SKIN MASS 20
501 THERAPY CHANGE 20
502 VERTIGO 20
503 ABULIA 19
504 APHONIA 19
505 ATRIAL FIBRILLATION 19
506 BREAST MASS 19
507 DISEASE PROGRESSION 19
508 DRUG DISPENSING ERROR 19
509 INJECTION SITE INFLAMMATION 19
510 LACRIMATION INCREASED 19
511 NEUROPATHY PERIPHERAL 19
512 SEPSIS 19
513 SKIN DISORDER 19
514 TROPONIN INCREASED 19
515 ABSCESS 18
516 ADVERSE REACTION 18
517 BIPOLAR I DISORDER 18
518 BLOOD POTASSIUM DECREASED 18
519 FEELING GUILTY 18
520 HORMONE LEVEL ABNORMAL 18
521 HYPOGLYCAEMIA 18
522 INAPPROPRIATE AFFECT 18
523 LIBIDO DISORDER 18
524 PERSONALITY DISORDER 18
525 PHOTOSENSITIVITY REACTION 18
526 POOR QUALITY PRODUCT ADMINISTERED 18
527 SCHIZOAFFECTIVE DISORDER BIPOLAR TYPE 18
528 TENDON DISORDER 18
529 THYROID DISORDER 18
530 TIC 18
531 ANTISOCIAL BEHAVIOUR 17
532 AUTISM SPECTRUM DISORDER 17
533 BACK DISORDER 17
534 BLEPHAROSPASM 17
535 EMERGENCY CARE 17
536 FEELING OF DESPAIR 17
537 FLATULENCE 17
538 FLUSHING 17
539 HAEMATOCHEZIA 17
540 HEPATIC STEATOSIS 17
541 HYPERTHERMIA 17
542 HYPOACUSIS 17
543 IMPAIRED GASTRIC EMPTYING 17
544 MASS 17
545 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 17
546 PSYCHOMOTOR SKILLS IMPAIRED 17
547 TOOTH DISORDER 17
548 TORTICOLLIS 17
549 ABASIA 16
550 ALCOHOL ABUSE 16
551 ARTHRITIS 16
552 DEAFNESS 16
553 DISSOCIATION 16
554 DYSPHEMIA 16
555 EXTRAOCULAR MUSCLE PARESIS 16
556 EYE SWELLING 16
557 FEELING JITTERY 16
558 HAEMORRHOIDS 16
559 HEART RATE DECREASED 16
560 HEPATIC CYTOLYSIS 16
561 LACTIC ACIDOSIS 16
562 MALNUTRITION 16
563 METABOLIC SYNDROME 16
564 SCAR 16
565 SELF-INJURIOUS IDEATION 16
566 THERAPY INTERRUPTED 16
567 ASPHYXIA 15
568 DEVICE BREAKAGE 15
569 DRUG SCREEN FALSE POSITIVE 15
570 FACIAL PARALYSIS 15
571 FEEDING DISORDER 15
572 FLUID RETENTION 15
573 FRACTURE 15
574 GASTROOESOPHAGEAL REFLUX DISEASE 15
575 HOMICIDE 15
576 HYPERAMMONAEMIC ENCEPHALOPATHY 15
577 HYPERMETABOLISM 15
578 HYPOMANIA 15
579 ILL-DEFINED DISORDER 15
580 IMPAIRED DRIVING ABILITY 15
581 INCORRECT DOSE ADMINISTERED BY DEVICE 15
582 INCORRECT STORAGE OF DRUG 15
583 INJECTION SITE HAEMATOMA 15
584 LIBIDO INCREASED 15
585 OBSESSIVE THOUGHTS 15
586 OCULAR HYPERAEMIA 15
587 PHYSICAL DECONDITIONING 15
588 POOR QUALITY DRUG ADMINISTERED 15
589 POSTURE ABNORMAL 15
590 PRODUCT PHYSICAL ISSUE 15
591 RESPIRATORY FAILURE 15
592 SACCADIC EYE MOVEMENT 15
593 SELF INJURIOUS BEHAVIOUR 15
594 SKIN BURNING SENSATION 15
595 TENSION 15
596 TORSADE DE POINTES 15
597 ABORTION SPONTANEOUS 14
598 ARTHROPATHY 14
599 ASTHMA 14
600 ATAXIA 14
601 HYPOKALAEMIA 14
602 INCORRECT DRUG ADMINISTRATION DURATION 14
603 INITIAL INSOMNIA 14
604 LIVER FUNCTION TEST ABNORMAL 14
605 LYMPHADENOPATHY 14
606 MUSCLE CONTRACTURE 14
607 NEGATIVE THOUGHTS 14
608 NEUTROPHIL COUNT INCREASED 14
609 RASH PRURITIC 14
610 SLOW SPEECH 14
611 STATUS EPILEPTICUS 14
612 TONGUE DISORDER 14
613 ALCOHOLISM 13
614 BLOOD CREATININE INCREASED 13
615 BREAST SWELLING 13
616 CARDIAC FLUTTER 13
617 COGWHEEL RIGIDITY 13
618 CONTRAINDICATED PRODUCT ADMINISTERED 13
619 CREATININE RENAL CLEARANCE DECREASED 13
620 DENTAL CARIES 13
621 DISEASE RECURRENCE 13
622 DRUG DELIVERY SYSTEM MALFUNCTION 13
623 EAR PAIN 13
624 EXCESSIVE EYE BLINKING 13
625 GAMBLING DISORDER 13
626 GENERALISED TONIC-CLONIC SEIZURE 13
627 GLAUCOMA 13
628 HOT FLUSH 13
629 INJECTION SITE CYST 13
630 INJECTION SITE DISCHARGE 13
631 LOSS OF EMPLOYMENT 13
632 MASTICATION DISORDER 13
633 MATERNAL EXPOSURE DURING PREGNANCY 13
634 MEDICAL DEVICE COMPLICATION 13
635 METABOLIC ACIDOSIS 13
636 NIGHT SWEATS 13
637 PNEUMONIA ASPIRATION 13
638 PRODUCT OUTER PACKAGING ISSUE 13
639 PSYCHOTIC BEHAVIOUR 13
640 RENAL PAIN 13
641 SEPTIC SHOCK 13
642 SLOW RESPONSE TO STIMULI 13
643 SUICIDAL BEHAVIOUR 13
644 TONGUE MOVEMENT DISTURBANCE 13
645 TOOTHACHE 13
646 TRANSIENT ISCHAEMIC ATTACK 13
647 UPPER RESPIRATORY TRACT INFECTION 13
648 WEIGHT FLUCTUATION 13
649 ACCIDENT 12
650 APPETITE DISORDER 12
651 BREAST ENGORGEMENT 12
652 CARDIAC FAILURE CONGESTIVE 12
653 DEVICE DEFECTIVE 12
654 DIZZINESS POSTURAL 12
655 DYSGEUSIA 12
656 DYSPHORIA 12
657 EXPOSURE TO CONTAMINATED DEVICE 12
658 FEELING COLD 12
659 GRANULOCYTOPENIA 12
660 HAEMATEMESIS 12
661 HYPERTHERMIA MALIGNANT 12
662 HYPERTONIA 12
663 HYPOTONIA 12
664 IMMOBILE 12
665 INJECTION SITE IRRITATION 12
666 LEUKOCYTOSIS 12
667 PRODUCT PHYSICAL CONSISTENCY ISSUE 12
668 PRODUCT TEMPERATURE EXCURSION ISSUE 12
669 PROTEIN TOTAL INCREASED 12
670 REDUCED FACIAL EXPRESSION 12
671 SARS-COV-2 TEST POSITIVE 12
672 SKIN EXFOLIATION 12
673 SYMPTOM RECURRENCE 12
674 TENDONITIS 12
675 THERAPEUTIC RESPONSE INCREASED 12
676 THROAT TIGHTNESS 12
677 VAGINAL HAEMORRHAGE 12
678 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 11
679 BLOOD GLUCOSE ABNORMAL 11
680 BLOOD GLUCOSE DECREASED 11
681 BLOOD OSMOLARITY DECREASED 11
682 BODY TEMPERATURE FLUCTUATION 11
683 BREAST DISORDER 11
684 CARDIO-RESPIRATORY ARREST 11
685 CHOLELITHIASIS 11
686 DEPENDENCE 11
687 DRUG WITHDRAWAL SYNDROME 11
688 DYSGRAPHIA 11
689 ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY 11
690 FIBROMYALGIA 11
691 HAIR GROWTH ABNORMAL 11
692 HYPERLIPIDAEMIA 11
693 INJECTION SITE SCAR 11
694 INJECTION SITE ULCER 11
695 JUDGEMENT IMPAIRED 11
696 LOCAL SWELLING 11
697 MENINGITIS 11
698 NO ADVERSE EVENT 11
699 PANCYTOPENIA 11
700 PATIENT ELOPEMENT 11
701 PLEURAL EFFUSION 11
702 PRESSURE OF SPEECH 11
703 PRODUCT STORAGE ISSUE 11
704 PROLACTIN-PRODUCING PITUITARY TUMOUR 11
705 RED BLOOD CELL COUNT DECREASED 11
706 REHABILITATION THERAPY 11
707 SINUSITIS 11
708 STUPOR 11
709 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 11
710 UNDERWEIGHT 11
711 ANION GAP INCREASED 10
712 ATRIOVENTRICULAR BLOCK FIRST DEGREE 10
713 BLADDER DISORDER 10
714 BLOOD BICARBONATE DECREASED 10
715 BRAIN NEOPLASM 10
716 BREATH ODOUR 10
717 CARDIOMYOPATHY 10
718 CYANOSIS 10
719 DEMENTIA ALZHEIMER^S TYPE 10
720 DIALYSIS 10
721 DRUG LEVEL BELOW THERAPEUTIC 10
722 DYSLIPIDAEMIA 10
723 EAR INFECTION 10
724 FEELING DRUNK 10
725 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10
726 GASTRIC DISORDER 10
727 GRIP STRENGTH DECREASED 10
728 HEPATIC NEOPLASM 10
729 ILLUSION 10
730 LAZINESS 10
731 LIMB INJURY 10
732 LIVER FUNCTION TEST INCREASED 10
733 MEGACOLON 10
734 MENSTRUATION DELAYED 10
735 MUSCULOSKELETAL DISORDER 10
736 MYELOCYTE COUNT INCREASED 10
737 NEAR DEATH EXPERIENCE 10
738 NICOTINE DEPENDENCE 10
739 ORTHOSTATIC HYPERTENSION 10
740 PHARYNGEAL OEDEMA 10
741 PHYSICAL DISABILITY 10
742 POLYURIA 10
743 PRESYNCOPE 10
744 PRODUCT CONTAINER ISSUE 10
745 PROTRUSION TONGUE 10
746 RESPIRATORY ARREST 10
747 SCHIZOPHRENIFORM DISORDER 10
748 SKIN REACTION 10
749 SOPOR 10
750 VIOLENCE-RELATED SYMPTOM 10
751 ACUTE RESPIRATORY FAILURE 9
752 AKINESIA 9
753 ASTHENOPIA 9
754 ATTENTION DEFICIT/HYPERACTIVITY DISORDER 9
755 BLAST CELL COUNT INCREASED 9
756 CARDIAC DISCOMFORT 9
757 CLUMSINESS 9
758 CYST 9
759 DERMO-HYPODERMITIS 9
760 DIABETIC COMA 9
761 DIET REFUSAL 9
762 DILATED CARDIOMYOPATHY 9
763 DRUG USE DISORDER 9
764 ERECTION INCREASED 9
765 EXERCISE TOLERANCE DECREASED 9
766 FRUSTRATION TOLERANCE DECREASED 9
767 FUNGAL INFECTION 9
768 GASTRITIS 9
769 HAIR TEXTURE ABNORMAL 9
770 HYPERTRIGLYCERIDAEMIA 9
771 INJECTION SITE DISCOLOURATION 9
772 LACK OF INJECTION SITE ROTATION 9
773 LIPIDS INCREASED 9
774 MALE SEXUAL DYSFUNCTION 9
775 MENORRHAGIA 9
776 MONOPLEGIA 9
777 MUSCULOSKELETAL CHEST PAIN 9
778 MUTISM 9
779 NEGLECT OF PERSONAL APPEARANCE 9
780 NEURALGIA 9
781 NYSTAGMUS 9
782 OSTEOPOROSIS 9
783 PANIC REACTION 9
784 PRESCRIBED OVERDOSE 9
785 PRODUCT COLOUR ISSUE 9
786 PRODUCT FORMULATION ISSUE 9
787 PRODUCT PRESCRIBING ISSUE 9
788 PRODUCT SUBSTITUTION ISSUE 9
789 SELF-DESTRUCTIVE BEHAVIOUR 9
790 SENSORY LOSS 9
791 SKIN LESION 9
792 SNEEZING 9
793 SPERMATOZOA ABNORMAL 9
794 STAPHYLOCOCCAL INFECTION 9
795 TERMINAL STATE 9
796 TRANSAMINASES INCREASED 9
797 UMBILICAL HERNIA 9
798 VITAMIN D DEFICIENCY 9
799 ANAPHYLACTIC SHOCK 8
800 APLASTIC ANAEMIA 8
801 AUTONOMIC NERVOUS SYSTEM IMBALANCE 8
802 BICYTOPENIA 8
803 BINGE EATING 8
804 BLOOD BILIRUBIN INCREASED 8
805 BLOOD LACTIC ACID INCREASED 8
806 BLOOD PRESSURE FLUCTUATION 8
807 BLOOD URIC ACID INCREASED 8
808 BRAIN OEDEMA 8
809 CHROMATURIA 8
810 COLD SWEAT 8
811 COMPULSIVE SHOPPING 8
812 CYSTITIS 8
813 DEPRESSION SUICIDAL 8
814 DISORGANISED SPEECH 8
815 DRUG ABUSER 8
816 DRUG TOLERANCE DECREASED 8
817 EAR DISORDER 8
818 FAECES DISCOLOURED 8
819 FOOD CRAVING 8
820 FORMICATION 8
821 GASTROENTERITIS 8
822 GENERAL PHYSICAL CONDITION ABNORMAL 8
823 GLOMERULAR FILTRATION RATE DECREASED 8
824 HAEMATOMA 8
825 HEPATIC FUNCTION ABNORMAL 8
826 HEPATITIS 8
827 HERNIA 8
828 HYPERCHOLESTEROLAEMIA 8
829 HYPERSEXUALITY 8
830 IMPATIENCE 8
831 INCORRECT PRODUCT ADMINISTRATION DURATION 8
832 JOINT DISLOCATION 8
833 LIP DISORDER 8
834 LIVER INJURY 8
835 METAMYELOCYTE COUNT INCREASED 8
836 MIDDLE INSOMNIA 8
837 MIOSIS 8
838 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8
839 MYDRIASIS 8
840 NEOPLASM 8
841 NEPHROLITHIASIS 8
842 PANIC DISORDER 8
843 PEMPHIGOID 8
844 PLEUROTHOTONUS 8
845 POST-INJECTION DELIRIUM SEDATION SYNDROME 8
846 PRODUCT PACKAGING QUANTITY ISSUE 8
847 PSYCHOMOTOR RETARDATION 8
848 READING DISORDER 8
849 SCHIZOPHRENIA, PARANOID TYPE 8
850 SINUS BRADYCARDIA 8
851 SINUS NODE DYSFUNCTION 8
852 SKIN ODOUR ABNORMAL 8
853 SKULL FRACTURE 8
854 SOMNAMBULISM 8
855 THOUGHT BLOCKING 8
856 UPPER LIMB FRACTURE 8
857 VIRAL INFECTION 8
858 WHEEZING 8
859 AGEUSIA 7
860 ALEXITHYMIA 7
861 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 7
862 APPLICATION SITE PAIN 7
863 ATTENTION DEFICIT HYPERACTIVITY DISORDER 7
864 BLOOD DISORDER 7
865 BRONCHITIS 7
866 CEREBRAL HAEMORRHAGE 7
867 CHRONIC KIDNEY DISEASE 7
868 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7
869 DECREASED ACTIVITY 7
870 DEPRESSIVE SYMPTOM 7
871 DEREALISATION 7
872 DIABETES MELLITUS INADEQUATE CONTROL 7
873 DRUG WITHDRAWAL SYNDROME NEONATAL 7
874 ECONOMIC PROBLEM 7
875 ELECTROCARDIOGRAM ABNORMAL 7
876 ELECTROLYTE IMBALANCE 7
877 ENERGY INCREASED 7
878 EYE DISCHARGE 7
879 EYELID PTOSIS 7
880 FACIAL ASYMMETRY 7
881 FAECALOMA 7
882 FOETAL DISTRESS SYNDROME 7
883 HAEMODYNAMIC INSTABILITY 7
884 HALLUCINATION, OLFACTORY 7
885 HALLUCINATION, TACTILE 7
886 HEART RATE ABNORMAL 7
887 HEPATIC FAILURE 7
888 HYPERAESTHESIA 7
889 HYPOXIA 7
890 INJECTION SITE HYPOAESTHESIA 7
891 INJECTION SITE OEDEMA 7
892 INTELLECTUAL DISABILITY 7
893 INTRUSIVE THOUGHTS 7
894 LABORATORY TEST ABNORMAL 7
895 LARYNGITIS 7
896 LUNG DISORDER 7
897 MALIGNANT CATATONIA 7
898 MOANING 7
899 MULTIPLE SCLEROSIS 7
900 MUSCLE FATIGUE 7
901 OROMANDIBULAR DYSTONIA 7
902 PARADOXICAL DRUG REACTION 7
903 PHOTOPSIA 7
904 PREMATURE BABY 7
905 PRODUCT LABEL CONFUSION 7
906 PRODUCTIVE COUGH 7
907 PROSTATIC PAIN 7
908 PULMONARY CONGESTION 7
909 PULMONARY OEDEMA 7
910 PULMONARY THROMBOSIS 7
911 RASH MACULAR 7
912 RESPIRATORY DISTRESS 7
913 RESPIRATORY TRACT INFECTION 7
914 RETCHING 7
915 SCRATCH 7
916 SHOULDER DEFORMITY 7
917 SKIN IRRITATION 7
918 SUPRAVENTRICULAR TACHYCARDIA 7
919 SUSPICIOUSNESS 7
920 TACHYPNOEA 7
921 TENDERNESS 7
922 URINE OUTPUT INCREASED 7
923 VENTRICULAR EXTRASYSTOLES 7
924 WATER INTOXICATION 7
925 WHEELCHAIR USER 7
926 WRONG PATIENT RECEIVED PRODUCT 7
927 ALCOHOL POISONING 6
928 BELLIGERENCE 6
929 BLOOD ALKALINE PHOSPHATASE INCREASED 6
930 BLOOD CHOLESTEROL ABNORMAL 6
931 BLOOD GLUCOSE FLUCTUATION 6
932 BLOOD PH DECREASED 6
933 BLOOD TEST ABNORMAL 6
934 BODY DYSMORPHIC DISORDER 6
935 CAFFEINE CONSUMPTION 6
936 CEREBRAL ATROPHY 6
937 DIPLEGIA 6
938 DRUG LEVEL ABNORMAL 6
939 DYSMENORRHOEA 6
940 EJACULATION DELAYED 6
941 ENTERITIS NECROTICANS 6
942 EOSINOPHILIA 6
943 FACE OEDEMA 6
944 FEMUR FRACTURE 6
945 GALLBLADDER DISORDER 6
946 GAZE PALSY 6
947 GRANDIOSITY 6
948 HEPATITIS C 6
949 HEPATOMEGALY 6
950 HICCUPS 6
951 HYPERACUSIS 6
952 HYPERTENSIVE CRISIS 6
953 HYPERTHYROIDISM 6
954 HYPERVENTILATION 6
955 HYPOPNOEA 6
956 IMPULSE-CONTROL DISORDER 6
957 INCORRECT DOSAGE ADMINISTERED 6
958 INFERTILITY FEMALE 6
959 INFERTILITY MALE 6
960 INJECTION SITE URTICARIA 6
961 INJECTION SITE VESICLES 6
962 INTENSIVE CARE 6
963 INTESTINAL ISCHAEMIA 6
964 JOINT INJURY 6
965 LACERATION 6
966 MASKED FACIES 6
967 MEIGE^S SYNDROME 6
968 MULTIPLE ALLERGIES 6
969 MULTIPLE FRACTURES 6
970 MUSCLE CONTRACTIONS INVOLUNTARY 6
971 MUSCLE STRAIN 6
972 MYOCLONUS 6
973 NEUTROPHILIA 6
974 NIPPLE PAIN 6
975 NOCTURIA 6
976 ORGASM ABNORMAL 6
977 PENILE SIZE REDUCED 6
978 PERICARDITIS 6
979 PLATELET COUNT INCREASED 6
980 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6
981 PRODUCT TAMPERING 6
982 PRURITUS GENERALISED 6
983 RASH ERYTHEMATOUS 6
984 RED CELL DISTRIBUTION WIDTH INCREASED 6
985 SCIATICA 6
986 SHOCK 6
987 STRABISMUS 6
988 SUPRAVENTRICULAR EXTRASYSTOLES 6
989 SYPHILIS 6
990 TEARFULNESS 6
991 THERMAL BURN 6
992 THROAT IRRITATION 6
993 UTERINE CANCER 6
994 VIITH NERVE PARALYSIS 6
995 VISUAL FIELD DEFECT 6
996 WITHDRAWAL CATATONIA 6
997 WOUND 6
998 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6
999 ACUTE HEPATIC FAILURE 5